Albert Bourla, Pfizer CEO (Matthew Busch/Bloomberg via Getty Images)
Changing course, Pfizer decides to sell off stake in GSK's consumer health spinoff
GSK’s consumer health spinoff Haleon is expected to list on the London stock exchange next month. But don’t expect Pfizer to stick along for the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
